The agency will fund studies of the molecular profiles of multiple brain regions and cell types to better understand the mechanisms of psychiatric diseases.
They also put forth a proof-of-concept method for scheduled Swath acquisition, which accounts for changes in precursor ion distributions across LC gradients.
According to study leader Neil Kelleher, the effort marks a significant step forward for the use of top-down proteomics in analyzing histone proteoforms.
Using the technique, the researchers collected phosphoproteomic data on 91 mouse liver samples, generating time-resolved profiles of insulin signaling.
The company is preparing a clinical study through which it will collect data that it will use to submit the device to FDA for 510(k) clearance next year.
This Week in Nucleic Acids Research: Researchers describe a new method to find large-scale structural variants in cancer genomes, a glimpse at an approach for profiling miRNAs in tumor samples from TCGA, and more.
Intellia Therapeutics has raised $70 million, becoming the latest firm leveraging the gene editing technology to haul in a gob of cash.
Now going beyond reporting fetal aneuploidies, NIPTs may be providing too much information that may be useless, some doctors and genetic counselor say.
A group of organizations in the UK say that there needs to be discussions about the use of technologies such as CRISPR/Cas-9 for human germline editing.